| Property name | Tool | Property value |
|---|---|---|
| Molecular weight (g/mol) | RDKit | 310.44 |
| Log P | RDKit | 5.73 |
| Topological polar surface area (Å2) | RDKit | 29.46 |
| Number of hydrogen bond acceptors | RDKit | 2 |
| Number of hydrogen bond donors | RDKit | 1 |
| Number of carbon atoms | RDKit | 21 |
| Number of heavy atoms | RDKit | 23 |
| Number of heteroatoms | RDKit | 2 |
| Number of nitrogen atoms | RDKit | 0 |
| Number of sulfur atoms | RDKit | 0 |
| Number of chiral carbon atoms | RDKit | 0 |
| Stereochemical complexity | RDKit | 0 |
| Number of sp hybridized carbon atoms | RDKit | 0 |
| Number of sp2 hybridized carbon atoms | RDKit | 12 |
| Number of sp3 hybridized carbon atoms | RDKit | 9 |
| Shape complexity | RDKit | 0.43 |
| Number of rotatable bonds | RDKit | 4 |
| Number of aliphatic carbocycles | RDKit | 0 |
| Number of aliphatic heterocycles | RDKit | 1 |
| Number of aliphatic rings | RDKit | 1 |
| Number of aromatic carbocycles | RDKit | 2 |
| Number of aromatic heterocycles | RDKit | 0 |
| Number of aromatic rings | RDKit | 2 |
| Total number of rings | RDKit | 3 |
| Number of saturated carbocycles | RDKit | 0 |
| Number of saturated heterocycles | RDKit | 0 |
| Number of saturated rings | RDKit | 0 |
| Number of Smallest Set of Smallest Rings (SSSR) | RDKit | 3 |
| Property name | Tool | Property value |
|---|---|---|
| Number of Lipinski’s rule of 5 violations | RDKit | 1 |
| Lipinski’s rule of 5 filter | RDKit | Passed |
| Number of Ghose filter violations | RDKit | 1 |
| Ghose filter | RDKit | Failed |
| Veber filter | RDKit | Good |
| Pfizer 3/75 filter | RDKit | Bad |
| GSK 4/400 filter | RDKit | Bad |
| Weighted quantitative estimate of drug-likeness (QEDw) score | RDKit | 0.730913 |
| Property name | Tool | Property value |
|---|---|---|
| Bioavailability score | SwissADME | 0.55 |
| Solubility class [ESOL] | SwissADME | Moderately soluble |
| Solubility class [Silicos-IT] | SwissADME | Poorly soluble |
| Blood Brain Barrier permeation | SwissADME | Yes |
| Gastrointestinal absorption | SwissADME | High |
| Log Kp (Skin permeation, cm/s) | SwissADME | -3.86 |
| Number of PAINS structural alerts | SwissADME | 0 |
| Number of Brenk structural alerts | SwissADME | 0 |
| CYP1A2 inhibitor | SwissADME | Yes |
| CYP2C19 inhibitor | SwissADME | Yes |
| CYP2C9 inhibitor | SwissADME | No |
| CYP2D6 inhibitor | SwissADME | Yes |
| CYP3A4 inhibitor | SwissADME | No |
| P-glycoprotein substrate | SwissADME | Yes |
| IMPPAT target identifier | Gene identifier | HGNC symbol | Entrez Gene identifier | Source |
|---|---|---|---|---|
| TAR_EXP_000264 | ENSG00000138061 | CYP1B1 | 1545 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000187 | ENSG00000118432 | CNR1 | 1268 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000188 | ENSG00000188822 | CNR2 | 1269 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000262 | ENSG00000140465 | CYP1A1 | 1543 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000263 | ENSG00000140505 | CYP1A2 | 1544 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_000265 | ENSG00000255974 | CYP2A6 | 1548 | BindingDB, ChEMBL |
| TAR_EXP_000825 | ENSG00000111716 | LDHB | 3945 | ChEMBL |
| TAR_EXP_000279 | ENSG00000134716 | CYP2J2 | 1573 | ChEMBL |
| TAR_EXP_000293 | ENSG00000167723 | TRPV3 | 162514 | BindingDB, ChEMBL |
| TAR_EXP_000591 | ENSG00000138744 | NAAA | 27163 | ChEMBL, NPASS |
| TAR_EXP_000773 | ENSG00000169083 | AR | 367 | NPASS |
| TAR_EXP_001054 | ENSG00000187688 | TRPV2 | 51393 | ChEMBL |
| TAR_EXP_001171 | ENSG00000132170 | PPARG | 5468 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001206 | ENSG00000042088 | TDP1 | 55775 | ChEMBL, NPASS |
| TAR_EXP_001354 | ENSG00000111199 | TRPV4 | 59341 | ChEMBL |
| TAR_EXP_001670 | ENSG00000196689 | TRPV1 | 7442 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001675 | ENSG00000134780 | DAGLA | 747 | BindingDB, ChEMBL, NPASS |
| TAR_EXP_001857 | ENSG00000104321 | TRPA1 | 8989 | ChEMBL |
| TAR_EXP_000270 | ENSG00000197408 | CYP2B6 | 1555 | ChEMBL |
